ArticleJournal of experimental & clinical cancer research : CR2020

Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.

Jiao Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.